scholarly article | Q13442814 |
P356 | DOI | 10.3171/2016.8.JNS161197 |
P8608 | Fatcat ID | release_ndl7b2qhtfh4nm6eb3y6ygastq |
P932 | PMC publication ID | 6086125 |
P698 | PubMed publication ID | 28059653 |
P50 | author | Khadijeh Bijangi-Vishehsaraei | Q87417010 |
Stacey L. Halum | Q93819249 | ||
Aaron A. Cohen-Gadol | Q60780622 | ||
Karen E. Pollok | Q64589654 | ||
P2093 | author name string | Haiyan Wang | |
Jann N Sarkaria | |||
Ahmad R Safa | |||
M Reza Saadatzadeh | |||
Wenjing Cai | |||
Malgorzata M Kamocka | |||
Angie Nguyen | |||
P2860 | cites work | Isothiocyanates inhibit the invasion and migration of C6 glioma cells by blocking FAK/JNK-mediated MMP-9 expression. | Q38833331 |
miR-144-3p exerts anti-tumor effects in glioblastoma by targeting c-Met | Q38845681 | ||
Sulforaphane induces DNA damage and mitotic abnormalities in human osteosarcoma MG-63 cells: correlation with cell cycle arrest and apoptosis | Q39036074 | ||
CD133 is essential for glioblastoma stem cell maintenance. | Q39212552 | ||
Sulforaphane induces DNA single strand breaks in cultured human cells. | Q39699012 | ||
Sulforaphane down-regulates COX-2 expression by activating p38 and inhibiting NF-kappaB-DNA-binding activity in human bladder T24 cells. | Q39872567 | ||
The transcription factor Nrf2 is a therapeutic target against brain inflammation | Q39970287 | ||
Suppression of NF-kappaB and NF-kappaB-regulated gene expression by sulforaphane and PEITC through IkappaBalpha, IKK pathway in human prostate cancer PC-3 cells. | Q40430279 | ||
Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide | Q40522471 | ||
Sulforaphane: a naturally occurring mammary carcinoma mitotic inhibitor, which disrupts tubulin polymerization | Q40623161 | ||
Stem cell niches in glioblastoma: a neuropathological view | Q41451541 | ||
Sulforaphane protects brains against hypoxic-ischemic injury through induction of Nrf2-dependent phase 2 enzyme | Q43086438 | ||
Sulforaphane enhances the therapeutic potential of TRAIL in prostate cancer orthotopic model through regulation of apoptosis, metastasis, and angiogenesis | Q46267077 | ||
Sulforaphane induces DNA double strand breaks predominantly repaired by homologous recombination pathway in human cancer cells | Q46317528 | ||
Sulforaphane induces apoptosis in human hepatic cancer cells through inhibition of 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase4, mediated by hypoxia inducible factor-1-dependent pathway. | Q54585085 | ||
Use of an orthotopic xenograft model for assessing the effect of epidermal growth factor receptor amplification on glioblastoma radiation response. | Q55470277 | ||
Selective cytostatic and cytotoxic effects of glucosinolates hydrolysis products on human colon cancer cells in vitro | Q74337652 | ||
Anti-carcinogenic effects of sulforaphane in association with its apoptosis-inducing and anti-inflammatory properties in human cervical cancer cells | Q85213795 | ||
Cytotoxic and Antitumor Activity of Sulforaphane: The Role of Reactive Oxygen Species | Q26799560 | ||
Cellular stress responses, hormetic phytochemicals and vitagenes in aging and longevity | Q27024064 | ||
Dietary Sulforaphane in Cancer Chemoprevention: The Role of Epigenetic Regulation and HDAC Inhibition | Q27026986 | ||
MGMT gene silencing and benefit from temozolomide in glioblastoma | Q27824832 | ||
Cancer statistics, 2013 | Q27860762 | ||
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma | Q27860910 | ||
Taxol induces caspase-10-dependent apoptosis | Q28285037 | ||
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial | Q29547224 | ||
Bioactive dietary supplements reactivate ER expression in ER-negative breast cancer cells by active chromatin modifications | Q34291226 | ||
Sulforaphane as a promising molecule for fighting cancer | Q34376869 | ||
Sulforaphane suppresses polycomb group protein level via a proteasome-dependent mechanism in skin cancer cells | Q35415785 | ||
4-(4-Chloro-2-methylphenoxy)-N-hydroxybutanamide (CMH) targets mRNA of the c-FLIP variants and induces apoptosis in MCF-7 human breast cancer cells | Q35668904 | ||
Glioblastoma stem cells (GSCs) epigenetic plasticity and interconversion between differentiated non-GSCs and GSCs. | Q35794896 | ||
DNA damage by drugs and radiation: what is important and how is it measured? | Q36022419 | ||
Reactive oxygen species-mediated therapeutic response and resistance in glioblastoma | Q36347143 | ||
Deadly teamwork: neural cancer stem cells and the tumor microenvironment | Q36386525 | ||
Sulforaphane retards the growth of human PC-3 xenografts and inhibits HDAC activity in human subjects. | Q36496614 | ||
Emerging targets for glioblastoma stem cell therapy | Q36502009 | ||
Wnt/β-catenin signaling is a key downstream mediator of MET signaling in glioblastoma stem cells | Q36544112 | ||
Gamma-H2AX - a novel biomarker for DNA double-strand breaks. | Q37210367 | ||
HDAC turnover, CtIP acetylation and dysregulated DNA damage signaling in colon cancer cells treated with sulforaphane and related dietary isothiocyanates | Q37378670 | ||
Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeutics | Q37761935 | ||
Targeting cancer stem cells with sulforaphane, a dietary component from broccoli and broccoli sprouts | Q38125500 | ||
Modulation of mitochondrial functions by the indirect antioxidant sulforaphane: a seemingly contradictory dual role and an integrative hypothesis | Q38133725 | ||
Stem cell signature in glioblastoma: therapeutic development for a moving target | Q38268185 | ||
Mitochondrial energy metabolism and apoptosis regulation in glioblastoma | Q38275798 | ||
Glioblastoma stem-like cells: at the root of tumor recurrence and a therapeutic target. | Q38287518 | ||
Mitochondrial reactive oxygen species and cancer. | Q38351698 | ||
Sulforaphane enhances caspase-dependent apoptosis through inhibition of cyclooxygenase-2 expression in human oral squamous carcinoma cells and nude mouse xenograft model | Q38498804 | ||
Sulforaphane sensitizes tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis through downregulation of ERK and Akt in lung adenocarcinoma A549 cells | Q38507607 | ||
How to train glioma cells to die: molecular challenges in cell death | Q38626416 | ||
Hypoxia Is the Driving Force Behind GBM and Could Be a New Tool in GBM Treatment | Q38630796 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | glioblastoma | Q282142 |
xenograft | Q64148587 | ||
tumour xenograft | Q112042499 | ||
P304 | page(s) | 1219-1230 | |
P577 | publication date | 2017-01-06 | |
P1433 | published in | Journal of Neurosurgery | Q15708886 |
P1476 | title | Sulforaphane suppresses the growth of glioblastoma cells, glioblastoma stem cell-like spheroids, and tumor xenografts through multiple cell signaling pathways | |
P478 | volume | 127 |
Q90711255 | Gomisin M2 from Baizuan suppresses breast cancer stem cell proliferation in a zebrafish xenograft model |
Q93018164 | Human bronchial carcinoid tumor initiating cells are targeted by the combination of acetazolamide and sulforaphane |
Q59807366 | Sulforaphane from Cruciferous Vegetables: Recent Advances to Improve Glioblastoma Treatment |
Search more.